ENTITY

Immuno Cure BioTech (2163385D CH)

Analysis

Health Care • Hong Kong

Immuno Cure BioTech Limited medical technology development businesses. The Company develops gene vaccines, antibody drugs, and other products. Immuno Cure BioTech conducts businesses in China and Hong Kong.

Refresh

No events found

We’ll display events we find for Immuno Cure BioTech here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00